Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05256771 · ClinicalTrials.gov registry record · NA

Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

A NA study of Muscle Tone Increased and Fat Reduction, sponsored by Venus Concept.

Active
Registry status
NA
Development phase
36
Enrollment target
3
Study locations

NCT05256771 is a NA study of Muscle Tone Increased and Fat Reduction that is active but no longer recruiting, run by Venus Concept. The registered enrollment target is 36 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05256771, a NA study of Muscle Tone Increased and Fat Reduction, is active but no longer recruiting, sponsored by Venus Concept.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
3
Study locations

Study Summary

Multi-center, three-arm, randomized, evaluator-blinded study of electrical muscle stimulation (EMS) and/or 1064 nm diode laser, pulsed electromagnetic field (PEMF) and vacuum assisted radio frequency (RF) using the Venus Bliss Max for fat reduction, body contouring and aesthetic improvement.

Interventions

  • DEVICE EMS
  • DEVICE 1064 nm diode laser
  • DEVICE RF/PEMF

Study Locations (3)

California

  • Scripps Clinical Research - General Medicine - San Diego

New Jersey

  • Schweiger Dermatology Group - Hackensack

Tennessee

  • Tennessee Clinical Research Center - Nashville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-11-01
Est. Completion 2025-09-30
Phase NA

Sponsor

Venus Concept

22 total trials

What the Registry Record Tells You About NCT05256771

The ClinicalTrials.gov registry entry for NCT05256771 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Muscle Tone Increased appearing as the primary indexed condition, and to 3 interventions - of which EMS is the first listed.

NCT05256771 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New Jersey, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05256771 about?

NCT05256771 is a clinical study titled "Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.". Multi-center, three-arm, randomized, evaluator-blinded study of electrical muscle stimulation (EMS) and/or 1064 nm diode laser, pulsed electromagnetic field (PEMF) and vacuum assisted radio frequency (RF) using the Venus Bliss Max for fat reduction, body contouring and aesthetic improvement.

What is the current status of trial NCT05256771?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2021-11-01. Estimated completion is 2025-09-30.

What conditions does trial NCT05256771 study?

This clinical trial studies the following conditions: Muscle Tone Increased, Fat Reduction.

What interventions are being tested in trial NCT05256771?

The interventions under investigation include: EMS (DEVICE), 1064 nm diode laser (DEVICE), RF/PEMF (DEVICE).

Who is sponsoring clinical trial NCT05256771?

This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05256771 being conducted?

This trial has 3 study locations across California, New Jersey, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscle Tone Increased

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.